Balchem Corporation
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $643.7M | $594.8M | $553.2M | $552.5M | $541.4M | $337.2M | $310.4M | $291.9M |
| Cost of Revenue | $439.4M | $405.8M | $372.3M | $384.4M | $397.2M | $239.8M | $220.9M | $205.9M |
| Gross Profit | $204.3M | $189.0M | $180.9M | $168.1M | $144.2M | $97.4M | $89.5M | $86.0M |
| Gross Margin | 31.7% | 31.8% | 32.7% | 30.4% | 26.6% | 28.9% | 28.8% | 29.5% |
| Operating Expenses | ||||||||
| Research & Development | $11.6M | $9.3M | $7.3M | $6.0M | $4.8M | $3.6M | $3.4M | $2.9M |
| SG&A Expense | $28.3M | $28.1M | $27.5M | $2.9M | $2.9M | $12.3M | $10.4M | $10.6M |
| Operating Income | $107.1M | $96.9M | $90.8M | $94.0M | $82.1M | $65.6M | $59.8M | $56.2M |
| Operating Margin | 16.6% | 16.3% | 16.4% | 17.0% | 15.2% | 19.5% | 19.3% | 19.3% |
| Interest Expense | — | $7.5M | $7.3M | $6.6M | $5.1M | $24.0K | $10.0K | $84.0K |
| Pretax Income | $99.0M | $88.5M | $82.9M | $87.1M | $77.1M | $65.8M | $59.8M | $56.7M |
| Income Tax Expense | $20.5M | $-1.6M | $27.0M | $27.3M | $24.2M | $20.9M | $19.8M | $18.0M |
| Net Income | $78.6M | $90.1M | $56.0M | $59.7M | $52.8M | $44.9M | $40.0M | $38.8M |
| Net Margin | 12.2% | 15.1% | 10.1% | 10.8% | 9.8% | 13.3% | 12.9% | 13.3% |
| EPS (Basic) | $2.45 | $2.83 | $1.78 | $1.92 | $1.74 | $1.51 | $1.38 | $1.36 |
| EPS (Diluted) | $2.42 | $2.79 | $1.75 | $1.89 | $1.69 | $1.45 | $1.32 | $1.28 |
| Shares Outstanding (Basic) | 32.1M | 31.8M | 31.5M | 31.2M | 30.4M | 29.6M | 29.0M | 28.6M |
| Shares Outstanding (Diluted) | 32.4M | 32.2M | 31.9M | 31.6M | 31.2M | 30.8M | 30.4M | 30.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |